Cancer Vaccine Market Size (USD 94034.07 M) by 2032 By Types (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Applications Covered (Cervical Cancer, Prostate Cancer, Others) and Regional Forecast to 2032

Detailed TOC of Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2031

Table of Content

1 Cancer Vaccine Market Overview
1.1 Product Overview and Scope of Cancer Vaccine Market
1.2 Cancer Vaccine Market Segment by Type
1.2.1 Global Cancer Vaccine Market Sales Volume and CAGR (%) Comparison by Type (2017-2031)
1.3 Global Cancer Vaccine Market Segment by Application
1.3.1 Cancer Vaccine Market Consumption (Sales Volume) Comparison by Application (2017-2031)
1.4 Global Cancer Vaccine Market, Region Wise (2017-2031)
1.4.1 Global Cancer Vaccine Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2031)
1.4.2 United States Cancer Vaccine Market Status and Prospect (2017-2031)
1.4.3 Europe Cancer Vaccine Market Status and Prospect (2017-2031)
1.4.4 China Cancer Vaccine Market Status and Prospect (2017-2031)
1.4.5 Japan Cancer Vaccine Market Status and Prospect (2017-2031)
1.4.6 India Cancer Vaccine Market Status and Prospect (2017-2031)
1.4.7 Southeast Asia Cancer Vaccine Market Status and Prospect (2017-2031)
1.4.8 Latin America Cancer Vaccine Market Status and Prospect (2017-2031)
1.4.9 Middle East and Africa Cancer Vaccine Market Status and Prospect (2017-2031)
1.5 Global Market Size of Cancer Vaccine (2017-2031)
1.5.1 Global Cancer Vaccine Market Revenue Status and Outlook (2017-2031)
1.5.2 Global Cancer Vaccine Market Sales Volume Status and Outlook (2017-2031)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Cancer Vaccine Market

2 Industry Outlook
2.1 Cancer Vaccine Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Cancer Vaccine Market Drivers Analysis
2.4 Cancer Vaccine Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Cancer Vaccine Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Cancer Vaccine Industry Development

3 Global Cancer Vaccine Market Landscape by Player
3.1 Global Cancer Vaccine Sales Volume and Share by Player (2017-2022)
3.2 Global Cancer Vaccine Revenue and Market Share by Player (2017-2022)
3.3 Global Cancer Vaccine Average Price by Player (2017-2022)
3.4 Global Cancer Vaccine Gross Margin by Player (2017-2022)
3.5 Cancer Vaccine Market Competitive Situation and Trends
3.5.1 Cancer Vaccine Market Concentration Rate
3.5.2 Cancer Vaccine Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Cancer Vaccine Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Cancer Vaccine Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Cancer Vaccine Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Cancer Vaccine Market Under COVID-19
4.5 Europe Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Cancer Vaccine Market Under COVID-19
4.6 China Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Cancer Vaccine Market Under COVID-19
4.7 Japan Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Cancer Vaccine Market Under COVID-19
4.8 India Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Cancer Vaccine Market Under COVID-19
4.9 Southeast Asia Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Cancer Vaccine Market Under COVID-19
4.10 Latin America Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Cancer Vaccine Market Under COVID-19
4.11 Middle East and Africa Cancer Vaccine Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Cancer Vaccine Market Under COVID-19

5 Global Cancer Vaccine Sales Volume, Revenue, Price Trend by Type
5.1 Global Cancer Vaccine Sales Volume and Market Share by Type (2017-2022)
5.2 Global Cancer Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global Cancer Vaccine Price by Type (2017-2022)
5.4 Global Cancer Vaccine Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Cancer Vaccine Sales Volume, Revenue and Growth Rate of Preventive Cancer Vaccines (2017-2022)
5.4.2 Global Cancer Vaccine Sales Volume, Revenue and Growth Rate of Therapeutic Cancer Vaccines (2017-2022)

6 Global Cancer Vaccine Market Analysis by Application
6.1 Global Cancer Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global Cancer Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Cancer Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Cancer Vaccine Consumption and Growth Rate of Cervical Cancer (2017-2022)
6.3.2 Global Cancer Vaccine Consumption and Growth Rate of Prostate Cancer (2017-2022)
6.3.3 Global Cancer Vaccine Consumption and Growth Rate of Others (2017-2022)

7 Global Cancer Vaccine Market Forecast (2022-2031)
7.1 Global Cancer Vaccine Sales Volume, Revenue Forecast (2022-2031)
7.1.1 Global Cancer Vaccine Sales Volume and Growth Rate Forecast (2022-2031)
7.1.2 Global Cancer Vaccine Revenue and Growth Rate Forecast (2022-2031)
7.1.3 Global Cancer Vaccine Price and Trend Forecast (2022-2031)
7.2 Global Cancer Vaccine Sales Volume and Revenue Forecast, Region Wise (2022-2031)
7.2.1 United States Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.2.2 Europe Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.2.3 China Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.2.4 Japan Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.2.5 India Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.2.6 Southeast Asia Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.2.7 Latin America Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.2.8 Middle East and Africa Cancer Vaccine Sales Volume and Revenue Forecast (2022-2031)
7.3 Global Cancer Vaccine Sales Volume, Revenue and Price Forecast by Type (2022-2031)
7.3.1 Global Cancer Vaccine Revenue and Growth Rate of Preventive Cancer Vaccines (2022-2031)
7.3.2 Global Cancer Vaccine Revenue and Growth Rate of Therapeutic Cancer Vaccines (2022-2031)
7.4 Global Cancer Vaccine Consumption Forecast by Application (2022-2031)
7.4.1 Global Cancer Vaccine Consumption Value and Growth Rate of Cervical Cancer(2022-2031)
7.4.2 Global Cancer Vaccine Consumption Value and Growth Rate of Prostate Cancer(2022-2031)
7.4.3 Global Cancer Vaccine Consumption Value and Growth Rate of Others(2022-2031)
7.5 Cancer Vaccine Market Forecast Under COVID-19

8 Cancer Vaccine Market Upstream and Downstream Analysis
8.1 Cancer Vaccine Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Cancer Vaccine Analysis
8.6 Major Downstream Buyers of Cancer Vaccine Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Cancer Vaccine Industry

9 Players Profiles
9.1 Immunomic Therapeutics, Inc.
9.1.1 Immunomic Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Cancer Vaccine Product Profiles, Application and Specification
9.1.3 Immunomic Therapeutics, Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 CSL Limited
9.2.1 CSL Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Cancer Vaccine Product Profiles, Application and Specification
9.2.3 CSL Limited Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Merck & Co., Inc.
9.3.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Cancer Vaccine Product Profiles, Application and Specification
9.3.3 Merck & Co., Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 PaxVax Corporation.
9.4.1 PaxVax Corporation. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Cancer Vaccine Product Profiles, Application and Specification
9.4.3 PaxVax Corporation. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Glaxosmithkline Plc
9.5.1 Glaxosmithkline Plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Cancer Vaccine Product Profiles, Application and Specification
9.5.3 Glaxosmithkline Plc Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sanpower Group
9.6.1 Sanpower Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Cancer Vaccine Product Profiles, Application and Specification
9.6.3 Sanpower Group Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Astrazeneca Plc.
9.7.1 Astrazeneca Plc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Cancer Vaccine Product Profiles, Application and Specification
9.7.3 Astrazeneca Plc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pfizer
9.8.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Cancer Vaccine Product Profiles, Application and Specification
9.8.3 Pfizer Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Dynavax Technologies Corporation
9.9.1 Dynavax Technologies Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Cancer Vaccine Product Profiles, Application and Specification
9.9.3 Dynavax Technologies Corporation Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Gritstone Oncology
9.10.1 Gritstone Oncology Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Cancer Vaccine Product Profiles, Application and Specification
9.10.3 Gritstone Oncology Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Sanofi Pasteur
9.11.1 Sanofi Pasteur Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Cancer Vaccine Product Profiles, Application and Specification
9.11.3 Sanofi Pasteur Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Aduro BioTech Inc.
9.12.1 Aduro BioTech Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Cancer Vaccine Product Profiles, Application and Specification
9.12.3 Aduro BioTech Inc. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Bavarian Nordic
9.13.1 Bavarian Nordic Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Cancer Vaccine Product Profiles, Application and Specification
9.13.3 Bavarian Nordic Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Astellas Pharma Inc.
9.14.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Cancer Vaccine Product Profiles, Application and Specification
9.14.3 Astellas Pharma Inc. Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source